CN113876671A - Anti-aging composition containing rape bud extract and preparation method thereof - Google Patents
Anti-aging composition containing rape bud extract and preparation method thereof Download PDFInfo
- Publication number
- CN113876671A CN113876671A CN202111374299.3A CN202111374299A CN113876671A CN 113876671 A CN113876671 A CN 113876671A CN 202111374299 A CN202111374299 A CN 202111374299A CN 113876671 A CN113876671 A CN 113876671A
- Authority
- CN
- China
- Prior art keywords
- extract
- aging
- aging composition
- rape
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 85
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 239000000284 extract Substances 0.000 title claims abstract description 56
- 238000000605 extraction Methods 0.000 title claims description 11
- 238000002360 preparation method Methods 0.000 title abstract description 37
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 claims abstract description 12
- 229940044176 ceramide 3 Drugs 0.000 claims abstract description 11
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 claims abstract description 10
- 239000000654 additive Substances 0.000 claims abstract description 5
- 230000000996 additive effect Effects 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 229940106189 ceramide Drugs 0.000 claims description 20
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 19
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 19
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 19
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 19
- 235000013311 vegetables Nutrition 0.000 claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 12
- 238000001816 cooling Methods 0.000 claims description 11
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- 239000003906 humectant Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 239000003755 preservative agent Substances 0.000 claims description 7
- 230000002335 preservative effect Effects 0.000 claims description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 238000009210 therapy by ultrasound Methods 0.000 claims description 6
- 235000011293 Brassica napus Nutrition 0.000 claims description 5
- 240000002791 Brassica napus Species 0.000 claims description 5
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 5
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 5
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 5
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 5
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 5
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 4
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 4
- 240000007817 Olea europaea Species 0.000 claims description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 230000003203 everyday effect Effects 0.000 claims description 4
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 4
- 229960002216 methylparaben Drugs 0.000 claims description 4
- 229940049964 oleate Drugs 0.000 claims description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 230000002745 absorbent Effects 0.000 claims description 3
- 239000002250 absorbent Substances 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 230000035784 germination Effects 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 2
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 claims description 2
- 229940043375 1,5-pentanediol Drugs 0.000 claims description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- NKEQOUMMGPBKMM-UHFFFAOYSA-N 2-hydroxy-2-[2-(2-hydroxy-3-octadecanoyloxypropoxy)-2-oxoethyl]butanedioic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O NKEQOUMMGPBKMM-UHFFFAOYSA-N 0.000 claims description 2
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 claims description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 2
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 2
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 claims description 2
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 claims description 2
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 2
- 108010020346 Polyglutamic Acid Proteins 0.000 claims description 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- 229960003237 betaine Drugs 0.000 claims description 2
- -1 caprylyl hydroxamic Chemical compound 0.000 claims description 2
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 claims description 2
- 229960003993 chlorphenesin Drugs 0.000 claims description 2
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 claims description 2
- 229940087068 glyceryl caprylate Drugs 0.000 claims description 2
- 229940075529 glyceryl stearate Drugs 0.000 claims description 2
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 claims description 2
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 claims description 2
- 229940100460 peg-100 stearate Drugs 0.000 claims description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 2
- 229960005323 phenoxyethanol Drugs 0.000 claims description 2
- 229920002643 polyglutamic acid Polymers 0.000 claims description 2
- 239000011736 potassium bicarbonate Substances 0.000 claims description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 2
- 235000011118 potassium hydroxide Nutrition 0.000 claims description 2
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 claims description 2
- 229960003415 propylparaben Drugs 0.000 claims description 2
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 229960002920 sorbitol Drugs 0.000 claims description 2
- 235000011303 Brassica alboglabra Nutrition 0.000 claims 6
- 240000007124 Brassica oleracea Species 0.000 claims 6
- 235000011302 Brassica oleracea Nutrition 0.000 claims 6
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims 1
- 239000003002 pH adjusting agent Substances 0.000 claims 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 230000037303 wrinkles Effects 0.000 abstract description 14
- 230000009759 skin aging Effects 0.000 abstract description 13
- 239000002537 cosmetic Substances 0.000 abstract description 12
- 230000007794 irritation Effects 0.000 abstract description 7
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 239000006071 cream Substances 0.000 abstract description 2
- 239000000686 essence Substances 0.000 description 51
- 210000003491 skin Anatomy 0.000 description 41
- 238000012360 testing method Methods 0.000 description 18
- 206010040954 Skin wrinkling Diseases 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 8
- 210000004204 blood vessel Anatomy 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 206010040914 Skin reaction Diseases 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 229960001631 carbomer Drugs 0.000 description 3
- 210000003711 chorioallantoic membrane Anatomy 0.000 description 3
- 239000000498 cooling water Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 238000000265 homogenisation Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- 230000035483 skin reaction Effects 0.000 description 3
- 231100000430 skin reaction Toxicity 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 2
- 241000208140 Acer Species 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000004266 Collagen Type IV Human genes 0.000 description 2
- 108010042086 Collagen Type IV Proteins 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 102000001187 Collagen Type III Human genes 0.000 description 1
- 108010069502 Collagen Type III Proteins 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 241001632410 Eleutherococcus senticosus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000927509 Heteropanax Species 0.000 description 1
- 241000927507 Heteropanax fragrans Species 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- BBAFBDLICMHBNU-MFZOPHKMSA-N N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC BBAFBDLICMHBNU-MFZOPHKMSA-N 0.000 description 1
- KZTJQXAANJHSCE-OIDHKYIRSA-N N-octodecanoylsphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC KZTJQXAANJHSCE-OIDHKYIRSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 210000003837 chick embryo Anatomy 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 125000005313 fatty acid group Chemical group 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 208000002741 leukoplakia Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
- 230000037331 wrinkle reduction Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/82—Preparation or application process involves sonication or ultrasonication
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses an anti-aging composition of a rape bud extract and a preparation method thereof, belonging to the field of cosmetics, wherein the composition is prepared from the rape bud extract, Heteropana leaf extract, palmitoyl pentapeptide-4, ceramide 3 and an additive; the anti-aging composition provided by the invention has low irritation, the synergistic enhancement effect of all components in the components can effectively resist free radicals, reduce skin wrinkles, tighten skin and delay skin aging, and the anti-aging composition can be added into essence, a mask and cream for use.
Description
Technical Field
The invention relates to the field of cosmetics, and particularly relates to an anti-aging composition containing a rape bud extract and a preparation method thereof.
Background
The skin is fine, smooth and elastic, which is the pursuit of every beauty lover and also the symbol of the youth activity of people. There are reports in the literature that human skin begins to age by 20-25 years, has long wrinkles, flaccid skin and gradually becomes mottled, and then the skin becomes flaccid, rough, dull, and wrinkles deepen and become more numerous. On one hand, as the people grow older, sebaceous gland secretion gradually decreases, and in addition, due to long-term sun exposure and adverse effects of free radicals, the epidermis gradually becomes thinner, the epidermis bulges, the nipple bodies are flat, the keratin production is reduced, the subcutaneous fat is reduced, so that sagging or wrinkles are caused, and the skin color is not as good as before, so that the people become more pale. On the other hand, the blood circulation of the skin is weakened, the resistance of blood vessels is weakened, and senile leukoplakia and senile wart are gradually generated, so that the skin is aged. Skin aging is almost accompanied by the second half of each person, which negatively affects the work and life of people, and thus how to delay aging is one of the research focuses on cosmetics.
Skin aging includes: 1. intrinsic or intrinsic aging: changes in skin histology and physiology due to inherent genetic factors; including epidermal atrophy, flattening of the dermal-epidermal interface, and dermal atrophy; 2. photo-aging: skin aging due to ultraviolet rays when exposed to sunlight; causing keratosis of the skin, freckles, wrinkles and elastosis. With the improvement of living standard and the emphasis on health, people who love beauty have the beauty, how to reduce the generation of wrinkles and recover youth, and anti-aging cosmetics increasingly become one of the products which are urgently needed by the majority of female consumers.
The skin aging inherent in the skin has a complex mechanism, and several theories are generally considered: 1. the theory of gene program control; 2. the theory of immunology; 3. the theory of free radicals; 4. the deletion of essential trace elements; 5. (ii) the theory of variation of enzyme activity; 6. the theory of hormones; 7. the theory of strain and sadness. The principle of action of cosmetic anti-aging products is to bring the balance of skin regeneration and degeneration to a normal state, i.e., to increase the synthesis of collagen and elastin. The general anti-aging products are mainly designed by adding some plant extracts, vitamin A derivatives, alpha-hydroxycarboxylic acid and the like, but many products have unsatisfactory effects. The main reasons are that the single efficacy, the poor cooperativity of each component, the unobvious effect, the poor permeability, the stimulation and the like are realized, the action principle is single, and the anti-aging effect is limited. The invention provides an anti-aging composition containing a rape bud extract and a preparation method thereof, aiming at solving the defects and shortcomings of the prior art.
Disclosure of Invention
Aiming at the problems, the invention provides an anti-aging composition containing a rape bud extract and a preparation method thereof, and aims to tighten skin and delay skin aging.
In order to achieve the above object, the present invention adopts the following technical solutions:
an anti-aging composition containing a rape bud extract is prepared from the following raw materials in parts by weight: 1-10 parts of rape bud extract, 1-10 parts of Heteropana leaf extract, 40.5-10 parts of palmitoyl pentapeptide, 30.5-10 parts of ceramide, 0.3-30 parts of additive and the balance of water.
Preferably, the additive comprises 0.1-1 part of preservative, 0.1-30 parts of humectant, 0.1-1 part of emulsifier and 0.1-1 part of pH regulator by weight.
Preferably, the preservative is composed of one or more of methyl hydroxybenzoate, propyl hydroxybenzoate, chlorphenesin, methylisothiazolinone, methylchloroisothiazolinone, phenoxyethanol, DMDM hydantoin, imidazolidinyl urea, 3-iodo-2-propynyl butyl carbamate, ethylhexyl glycerol, octyl glycol, caprylic hydroxamic acid, glyceryl caprylate, p-hydroxyacetophenone, 1, 2-hexanediol.
Preferably, the humectant consists of one or more of glycerin, propylene glycol, butylene glycol, sorbitol, pentylene glycol, sodium hyaluronate, polyglutamic acid, trehalose, and betaine.
Preferably, the emulsifier is composed of one or more of glyceryl stearate, glyceryl stearate citrate, PEG-100 stearate, hydrogenated lecithin, cetearyl olive oleate, sorbitan olive oleate, potassium cetyl phosphate, Tween 20, Tween 60, and polyglycerol-10-stearate.
Preferably, the PH regulator is composed of one or more of triethanolamine, sodium bicarbonate, potassium bicarbonate, sodium hydroxide, and potassium hydroxide.
Preferably, the preparation method of the anti-aging composition containing the rape bud extract comprises the following preparation steps:
(1) elutriating rape seeds for 2 times by using clear water at the temperature of 20-30 ℃, and soaking in warm water with the volume 2-3 times and the temperature of 45 ℃ for 24 hours; cleaning the seeds with clear water, filtering to remove water, and wrapping the seeds with gauze at 25 ℃ for accelerating germination for 48 h; uniformly placing the seeds in a seedling raising tray paved with wet paper, covering the seedling raising tray with wet gauze, and spraying water for 2-3 times every day; the tenth day, cleaning the sprouting vegetable sample, then drying the sprouting vegetable sample by using absorbent paper, freezing and drying the sprouting vegetable sample, and crushing the sprouting vegetable sample to obtain a crushed rape bud;
(2) pulverizing Heteropana leaf with pulverizer 25000R/min to obtain Heteropana leaf pulverized product;
(3) taking 30-50% of butanediol, 20-40% of ethanol and 10-20% of deionized water as solvents by mass, respectively and independently extracting the crushed rape bud and the crushed Heteropanar leaf, wherein the mass fraction ratio of the crushed materials to the solvents is 1: 20-30 parts of; controlling the extraction temperature at 50-60 deg.C, performing ultrasonic treatment for 40-60min during extraction, filtering after extraction, and concentrating under reduced pressure to constant weight to obtain vegetable sprout powder extract and Heteropana leaf extract;
(4) taking 60-70% of butanediol, 0.1-0.5% of Tween 20 and 100-200PPM of palmitoyl pentapeptide-4 in percentage by mass, and carrying out ultrasonic treatment for 40-60min, wherein the temperature is controlled at 30-40 ℃ to obtain a palmitoyl pentapeptide-4 solution;
(5) heating 95-99% of polyglycerol-10-stearate and 1-5% of ceramide 3 by mass to 70-85 ℃, and cooling to obtain a ceramide 3 raw material;
(6) and weighing the obtained extract and other components according to the weight part ratio, and mixing with the weighed preservative, humectant, emulsifier and pH regulator to obtain the anti-aging composition.
The efficacy of each component provided by the invention is as follows:
extract of rape (BRASSICA campseris) sprout: rape, one of the four world oil crops, has multiple functions of oil, vegetable, flower, honey, feed, fertilizer and the like. Contains a large amount of protein, grease, glucosinolate, polyphenol, phytic acid, polysaccharide, cellulose, sterol, saponin and other components, and has great application value.
Heteropanax (Heteropanax FRAGRANS) leaf extract: heteropana is evergreen tree of Heteropana of Araliaceae, also called as "Fugui tree", Dafugui, Guangmi maple, Dashe drug, Acanthopanax senticosus, Liangmazu, up to 30 m. The Chinese medicine Heteropanar maple is also named as Dashe medicine, Wujiatong and Liangmeimu. The root and bark are used as the medicine. Bitter in nature and taste, cool, clear heat and remove toxicity, activate blood and relieve swelling, and alleviate pain. Can be used for treating common cold, sunstroke and headache; it is used externally to treat carbuncle, furuncle, swelling toxin, lymphadenitis, fracture, burn, scald, sprain, contusion, and snake bite.
Palmitoyl pentapeptide-4, a messenger peptide, contains a tiny collagen fragment that plays a messenger role in the skin, specifically in dermal cells, signaling dermal fibroblasts to synthesize the essential components of the skin basal lamina: type I, type III and type IV collagen, and polysaccharides (mucopolysaccharides and hyaluronic acid). While type IV collagen is important for repairing the epidermal-dermal junction, it makes the skin more elastic and healthy.
Ceramide 3: ceramide (Ceramide) is a phospholipid with Ceramide as a skeleton, and is formed by covalently bonding long-chain sphingosine and fatty acid through amido bond. Ceramides can be classified into ceramide I, ceramide II, ceramide IIIA, ceramide IIIB, ceramide VI, etc. according to the length of sphingosine and fatty acid chains, the saturation, the number of hydroxyl groups, etc. 40% -50% of sebum in the stratum corneum is composed of ceramide, ceramide is the main part of intercellular matrix, not only is used as a second messenger molecule in the sphingomyelin pathway, but also plays an important role in the process of forming the stratum corneum of the epidermis, and has the functions of maintaining skin barrier, preserving moisture, resisting aging, whitening, treating diseases and the like, wherein the effect of ceramide 3 is the best.
The anti-aging composition provided by the invention has the following effects by optimizing component comparison and synergistically enhancing the effect: has effects in scavenging free radicals, reducing skin wrinkle, tightening skin, and delaying skin aging. Thereby effectively preventing and improving the skin aging,
the anti-aging composition provided by the invention can be widely applied to cosmetics, such as water, essence, emulsion, cream, mask and the like of the cosmetics.
Further, the invention also provides anti-aging essence containing the anti-aging composition.
Further, the anti-aging essence also comprises an auxiliary material for preparing the anti-aging composition into essence.
The anti-aging essence comprises the following components:
item A: deionized water, EDTA disodium, methylparaben, glycerin, butanediol, xanthan gum, carbomer, sodium hyaluronate,
Item B: octanoyl hydroximic acid, 1, 2-hexanediol
Item C: triethanolamine, triethanolamine,
Item D: anti-aging composition
The different raw materials are divided into different items according to the adding sequence, and after the heating and stirring treatment, the temperature is reduced, and the anti-aging composition is added, so that the essence with uniform components is finally obtained, is absorbed by the skin, can effectively resist free radicals, reduce skin wrinkles, tighten the skin and delay skin aging.
Further, the anti-aging essence comprises the following components in percentage by weight:
item A: 0.02 parts of EDTA disodium, 0.12 parts of methylparaben, 3.5 parts of glycerol, 3.5 parts of butanediol, 0.12 parts of xanthan gum, 0.12 parts of carbomer, 0.05 parts of sodium hyaluronate and the balance of deionized water;
item B, caprylyl hydroximic acid 0.03, 1, 2-hexanediol 0.55
C term triethanolamine 0.12
Item D: anti-aging composition
The anti-aging essence prepared by the raw materials in the weight ratio is mild in texture and easy to absorb, and can effectively resist free radicals, reduce skin wrinkles, tighten skin and delay skin aging.
The invention also provides a preparation method of the anti-aging essence, which comprises the following steps:
s1: putting the item A into a main pot, starting slow homogenization, heating to 85 ℃ when all the items are swelled and no particles exist, preserving heat for 30 minutes, starting cooling water, and starting cooling;
s2: cooling to about 45 ℃, putting the B item in another container, heating until the B item is completely dissolved, then putting the B item into a main pot, and uniformly stirring;
s3: then adding the item C, stirring for 3 to 5 minutes, and uniformly stirring;
s4: finally adding the anti-aging composition, stirring and stirring for 3 to 5 minutes;
s5: after the inspection is qualified, the material is discharged and filtered by a filter cloth of 150 meshes.
Due to the adoption of the technical scheme, the invention has the beneficial effects that:
(1) the anti-aging composition provided by the invention has synergistic interaction of all components, can effectively resist free radicals, reduce skin wrinkles, tighten skin and delay skin aging.
(2) The anti-aging essence provided by the invention selects various auxiliary materials with different proportioning relations, and the prepared essence has stable and uniform components and is easy to absorb.
(3) The anti-aging composition provided by the invention can be added into essence for use, the activity of effective active ingredients is kept through different component raw materials and different temperature adding methods, and the components are fully and uniformly mixed, stable in performance, simple and convenient to prepare and easy for large-scale production.
(4) The components of the invention have low irritation to raw materials, and the synergistic enhancement effect among the components can effectively resist free radicals, reduce skin wrinkles, tighten skin and delay skin aging.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments of the present invention without any inventive step, are within the scope of the present invention.
It should be noted that the raw materials used in the technical scheme provided by the invention are prepared by conventional means or purchased from commercial sources except for special instructions.
The rape seeds provided by the invention are purchased from: hebeixing, agriculture, Fumin seeds marketing Co., Ltd;
heteropana leaf was purchased from: tianrui medicinal materials business in millizhou city;
palmitoyl pentapeptide-4 was purchased from: tenbang, Guangzhou, Biotechnology, Inc.;
ceramide 3 was purchased from: cantonese China Nature biology Ltd
The invention provides an anti-aging composition containing a rape bud extract and a preparation method thereof.
The anti-aging essence comprises the following four components:
item A: deionized water, EDTA disodium, methylparaben, glycerol, butanediol, xanthan gum, carbomer and sodium hyaluronate;
item B: caprylyl hydroximic acid, 1, 2-hexanediol;
item C: triethanolamine;
item D: the anti-aging composition of the present invention.
The preparation method of the anti-aging composition containing the rape bud extract comprises the following preparation steps:
(1) the rape seeds are elutriated for 2 times by clear water at 20-30 ℃, and soaked in warm water with 2-3 times of volume and 45 ℃ for 24 hours. Washing the seeds with clear water, filtering to remove water, and wrapping with gauze at 25 deg.C for accelerating germination for 48 h. And then uniformly placing the seeds in a seedling raising tray paved with wet paper, covering the seedling raising tray with wet gauze, and spraying water for 2-3 times every day. On the tenth day, cleaning the sprouting vegetable sample, then, drying the sprouting vegetable sample by using absorbent paper, freezing and drying the sprouting vegetable sample, and then, crushing the sprouting vegetable sample to obtain a crushed rape bud;
(2) pulverizing Heteropana leaf with pulverizer 25000R/min to obtain Heteropana leaf pulverized product;
(3) taking 30-50% of butanediol, 20-40% of ethanol and 10-20% of deionized water as solvents by mass, respectively and independently extracting the crushed rape bud and the crushed Heteropanar leaf, wherein the mass fraction ratio of the crushed materials to the solvents is 1: 20-30 parts of; controlling the extraction temperature at 50-60 deg.C, performing ultrasonic treatment for 40-60min during extraction, filtering after extraction, and concentrating under reduced pressure to constant weight to obtain vegetable sprout powder extract and Heteropana leaf extract;
(4) taking 60-70% of butanediol, 0.1-0.5% of Tween 20 and 100-200PPM of palmitoyl pentapeptide-4 in percentage by mass, and carrying out ultrasonic treatment for 40-60min, wherein the temperature is controlled at 30-40 ℃ to obtain a palmitoyl pentapeptide-4 solution;
(5) heating 95-99% of polyglycerol-10-stearate and 1-5% of ceramide 3 to 70-85 ℃, cooling to obtain ceramide 3 raw material,
(6) and weighing the obtained extract and other components according to the weight part ratio, and mixing with the weighed preservative, humectant, emulsifier and pH regulator to obtain the anti-aging composition.
Example 1:
preparation of this example 1 the essence to which the anti-aging composition of the present invention was added was prepared:
the anti-aging composition comprises 25% of rape extract, 25% of Heteropanaxfragma leaf extract, 25% of palmitoyl pentapeptide-425% and 325% of ceramide anti-aging essence, and the specific preparation steps comprise the following steps:
(1) putting the component raw materials of the A component into a main pot, starting slow homogenization, heating to 85 ℃ when all the components are completely swelled and no particles exist, preserving the temperature for 30min, starting cooling water, starting cooling, and cooling to 60 ℃;
(2) adding the component raw material B into another container, heating until the component raw material B is completely dissolved, then putting the mixture into a main pot, uniformly stirring and mixing the mixture with the component raw material A, and cooling to 45 ℃;
(3) adding the component C into the main pot, mixing, stirring for 3-5min, and stirring;
(4) and finally, mixing and stirring the raw materials of each component for 3-5min, discharging and filtering the mixture by a filter cloth of 150 meshes after the raw materials are qualified, and thus obtaining the anti-aging essence of the embodiment 1.
Example 2:
preparation of this example 2 the essence to which the anti-aging composition of the present invention was added was:
in the formula, the anti-aging composition comprises 20% of rape extract, 20% of Heteropana leaf extract, 430% of palmitoyl pentapeptide and 330% of ceramide as anti-aging essence, and the specific preparation steps comprise:
the specific preparation steps of the anti-aging essence are the same as those of example 1.
Example 3:
preparation of this example 3 the essences of the anti-aging composition of the present invention added:
in the formula, the anti-aging composition comprises 30 percent of rape extract, 30 percent of Heteropana leaf extract, 420 percent of palmitoyl pentapeptide and 320 percent of ceramide anti-aging essence by weight percent, and the specific preparation steps comprise the following steps:
the specific preparation steps of the anti-aging essence are the same as those of example 1.
Example 4:
preparation of this example 4 the essence to which the anti-aging composition of the present invention was added was:
in the formula, the anti-aging composition comprises 20% of rape extract, 30% of Heteropana leaf extract, 420% of palmitoyl pentapeptide and 330% of ceramide as anti-aging essence, and the preparation method comprises the following steps:
the specific preparation steps of the anti-aging essence are the same as those of example 1.
Example 5:
preparation of this example 5 the essence to which the anti-aging composition of the present invention was added was:
in the formula, the anti-aging composition comprises 30% of rape extract, 20% of Heteropana leaf extract, 430% of palmitoyl pentapeptide and 320% of ceramide anti-aging essence, and the specific preparation steps comprise:
the specific preparation steps of the anti-aging essence are the same as those of example 1.
Example 6:
preparation of this example 6 the essence to which the anti-aging composition of the present invention was added was:
in the formula, the anti-aging composition comprises 15 percent of rape extract, 35 percent of Heteropanaxfragma leaf extract, 435 percent of palmitoyl pentapeptide and 315 percent of ceramide.
The specific preparation steps of the anti-aging essence are the same as those of example 1.
Example 7:
preparation of this example 7 with the addition of the essence of the anti-aging composition of the invention:
the anti-aging composition comprises 35% of rape extract, 15% of Heteropanar leaf extract, 415% of palmitoyl pentapeptide and 335% of ceramide.
The specific preparation steps of the anti-aging essence are the same as those of example 1.
Example 8:
preparation of this example 8 the essence to which the anti-aging composition of the present invention was added was:
the anti-aging composition comprises 35% of rape extract, 35% of Heteropanaxfragma leaf extract, 415% of palmitoyl pentapeptide and 315% of ceramide.
The specific preparation steps of the anti-aging essence are the same as those of example 1.
Example 9:
preparation of this example 9 with the addition of the essence of the anti-aging composition of the present invention:
the anti-aging composition comprises 35% of rape extract, 15% of Heteropanaxfragma leaf extract, 435% of palmitoyl pentapeptide and 315% of ceramide.
The specific preparation steps of the anti-aging essence are the same as those of example 1.
Example 10:
preparation of this example 10 with the addition of the essence of the anti-aging composition of the present invention:
the anti-aging composition comprises 40% of rape extract, 25% of Heteropanaxfragma leaf extract, 5-435% of palmitoyl pentapeptide and 320% of ceramide, wherein the specific preparation steps of the anti-aging essence are the same as those of example 1.
Comparative example 11:
the essence of this comparative example 11 was prepared:
the preparation method of the essence of comparative example 11 includes:
(1) putting the component raw materials of the A component into a main pot, starting slow homogenization, heating to 85 ℃ when all the components are completely swelled and no particles exist, preserving the temperature for 30min, starting cooling water, starting cooling, and cooling to 60 ℃;
(2) adding the component raw material B into another container, heating until the component raw material B is completely dissolved, then putting the component raw material B into a main pot, uniformly stirring the component raw material B and the component raw material A, and then cooling to 45 ℃;
(3) and (3) putting the component C raw materials into a main pot, mixing the component C raw materials with other raw materials, stirring for 3-5min, discharging the materials after the inspection is qualified, and filtering the materials by a filter cloth of 150 meshes to obtain the essence of the comparative example 11.
The efficacy evaluation was performed on the anti-aging essences provided in the above examples and comparative examples:
1. anti-irritation test:
the structure of chick chorioallantoic membrane is similar to that of eye conjunctiva, and the chorioallantoic membrane blood vessel experimental method evaluates potential irritation by observing the effect of a test substance on blood vessels, namely, the middle stage chorioallantoic membrane of a fertilized chick embryo with the embryo age of 10-14 days after incubation utilizes the characteristics of complete, obvious and transparent CAM blood vessel system to directly contact a certain amount of test substance with CAM, observe CAM blood vessel injury after a period of action, score different blood vessel injury degrees, and the more serious the blood vessel injury is, the larger the score is. The method particularly emphasizes the vascular effect of the detected object, such as ghost blood vessel, capillary blood vessel congestion, capillary blood vessel hemorrhage, etc. The NC value (stimulation value of normal use concentration) means that the value is graded according to the value corresponding to the CAM vascular effect, and the average value of a group of data is taken to determine the stimulation.
Evaluation of irritation:
grading standard:
examples evaluation of irritation:
| group of | NC scoring |
| Example 1 | 0.5 |
| Example 2 | 0.8 |
| Example 3 | 0.6 |
| Example 4 | 0.4 |
| Example 5 | 0.3 |
| Example 6 | 0.5 |
| Example 7 | 0.4 |
| Example 8 | 0.6 |
| Example 9 | 0.5 |
| Example 10 | 0.6 |
| Comparative example 11 | 1.2 |
As can be seen from the above data, the NC value scores in the embodiments 1-10 are all lower, and the anti-aging composition of the present invention can greatly reduce the irritation of the product itself, reduce the inadaptability of the product to the skin, is also suitable for people with sensitive muscles, and can maintain the steady state and basic health of the skin.
2. Safety test
The test method comprises the following steps: 110 volunteers of 25-45 years of age were selected. The skin health of the volunteers, no allergic constitution or cosmetic allergic history, no pregnancy, lactation period, no participation in the clinical test of the medicine within 30 days, or participation in other cosmetic human safety and efficacy testers are divided into 11 groups, the anti-aging essence of the examples 1-10 and the essence of the comparative example 11 are respectively tried, a qualified spot tester is selected, a sample of about 0.02g of the anti-aging essence is dropped into the spot tester in a closed spot-sticking experiment mode, an external special adhesive tape is pasted on the inner side of the forearm of the testee for 48h, and after the tested substances are removed, the skin reaction is respectively observed for 0.5, 6, 12, 24 and 48 h. The results were recorded according to the skin reaction grading Standard in "standards for hygiene of cosmetics".
The experimental results are as follows: the test result of the human body skin patch shows that: the subjects observed skin reactions at 0.5, 6, 12, 24, 48 hours, 0 of which showed adverse reactions to the skin, by testing the anti-aging essences of examples 1 to 10 and the essence of comparative example 11, indicating that the essence to which the anti-aging composition of the present invention was added was stable and safe, and no adverse reaction and irritation were found during long-term use of the product of the present invention.
3. Oxidation resistance test
Determination of DPPH scavenging Capacity
1mL of 0.01mg/mL sample solution in ethanol was transferred, 4mL of 0.1mmol/L DPPH reaction solution was added, and the mixture was shaken up. After the reaction is carried out for 30 minutes in a dark place, the absorbance A is measured at 517nm, the test is repeated for three times, and the average value is taken; meanwhile, the absorbance A0 is measured by using ethanol instead of the sample solution, and the calculation formula of DPPH-free radical clearance is as follows
DPPH-clearance (%) ═ a0/(a0-a) × 100.
In the formula: a0 is the absorbance of the control group; a is the absorbance of the sample.
Determination of ABTS clearing Capacity
Transferring 1mL of 0.01mg/mL sample solution in ethanol, adding 4mL of 0.1mmol/L ABTS working solution reaction solution, and shaking up. After 10 minutes of dark reaction, measuring the absorbance A at 734nm, and taking the average value; at the same time, the absorbance A0 was measured using ethanol instead of the sample solution.
ABTS · clearance (%) ═ a0/(a0-a) × 100.
In the formula: a0 is the absorbance of the control group; a is the absorbance of the sample.
The test results are given in the following table:
| sample (I) | DPPH clearance rate | ABTS clearance |
| Example 1 | 83.42 | 65.67 |
| Example 2 | 71.09 | 60.88 |
| Example 3 | 85.67 | 62.10 |
| Example 4 | 83.53 | 69.19 |
| Example 5 | 79.83 | 62.53 |
| Example 6 | 81.38 | 67.87 |
| Example 7 | 86.14 | 70.76 |
| Example 8 | 82.11 | 66.41 |
| Example 9 | 84.07 | 63.37 |
| Example 10 | 80.79 | 67.06 |
| Comparative example 11 | 5.67 | 2.42 |
The experimental results are as follows: examples 1-10, DPPH radical scavenging and ABTS radical scavenging, significantly greater than comparative example 11; has good antioxidant effect, and can be used for predicting that the skin can have good antioxidant effect, thereby delaying skin aging and enabling the skin to return to a healthy state.
4. Skin moisture, elasticity and wrinkle reduction test
The test method comprises the following steps: selecting volunteers with skin fine lines at age of 35-45 years. The volunteers have no pregnancy, no medicine clinical test within 30 days, or have 180 volunteers participating in other cosmetics, human body safety and efficacy test, and are divided into 12 groups, wherein the test is performed by respectively using examples 1-10, comparative example 11 and skin care products (repairing certain deep activating anti-wrinkle essence) with large market occupancy as a control group for comparison test, the using method comprises the steps of using the skin care products once in the morning and at night every day, the using period is 4 weeks, the facial skin is subjected to data acquisition and facial image photographing analysis before the product is tried, and the data is used as a skin initial value before the use and after the use of 4 weeks. Carrying out data acquisition and analysis, wherein the data is used as a skin result value, the test environment temperature is 25 ℃, and the humidity is 60%; testing each data for three times, calculating the average value of each group after taking the average value, and reserving two bits after decimal point; testing the change of the moisture content of the skin by using a moisture tester (Corneometer CM825) to evaluate the moisture retention degree of the product on the skin; measuring the change of the skin elasticity value with a skin elasticity tester (Cutomeerdual MPA 580); in addition, changes in skin texture were measured by the fast optical skin imaging method (FOITS method), which evaluates changes in the depth and length of wrinkles and fine lines in the fine line region and the crow's feet region around the eyes,
the test results show that after 4 weeks, the skin water content and elasticity are obviously increased and the wrinkle volume is obviously reduced by using the essence prepared by the compositions in the examples 1-10, which is obviously higher than that of the comparative example and the control group, so that the active ingredients of the rape bud extract, the Heteropana leaf extract, the palmitoyl pentapeptide-4 and the ceramide 3 can be reasonably matched to play the effects of all the components, the overall using effect is improved through the synergistic effect, and the essence can bring good moisturizing effect to the product, effectively enhance the skin elasticity, reduce the wrinkles and achieve the anti-aging effect by being added into the conventional cosmetic matrix.
The above examples are only intended to illustrate the technical solution of the present invention, but not to limit it; although the present invention has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some technical features may be equivalently replaced; and such modifications or substitutions do not depart from the spirit and scope of the corresponding technical solutions of the embodiments of the present invention.
Claims (7)
1. An anti-aging composition containing an oil vegetable sprout extract is characterized by being prepared from the following raw materials in parts by weight: 1-10 parts of rape bud extract, 1-10 parts of Heteropana leaf extract, 40.5-10 parts of palmitoyl pentapeptide, 30.5-10 parts of ceramide and 0.3-30 parts of additive.
2. The anti-aging composition containing Brassica oleracea sprout extract as claimed in claim 1, wherein said additive comprises 0.1-1 part by weight of preservative, 1-30 parts by weight of humectant, 0.1-1 part by weight of emulsifier, 0.1-1 part by weight of pH regulator, and the balance of water.
3. The anti-aging composition comprising sprout extract of Brassica oleracea as claimed in claim 2, wherein the preservative is comprised of one or more of methylparaben, propylparaben, chlorphenesin, methylisothiazolinone, methylchloroisothiazolinone, phenoxyethanol, DMDM hydantoin, imidazolidinyl urea, 3-iodo-2-propynyl butyl carbamate, ethylhexyl glycerol, capryl glycol, caprylyl hydroxamic acid, glyceryl caprylate, p-hydroxyacetophenone, 1,2 hexanediol.
4. The anti-aging composition containing Brassica oleracea sprout extract as claimed in claim 2, wherein said humectant consists of one or more of glycerin, propylene glycol, butylene glycol, sorbitol, pentylene glycol, sodium hyaluronate, polyglutamic acid, trehalose, and betaine.
5. The anti-aging composition comprising Brassica oleracea sprout extract of claim 2, wherein said emulsifier comprises one or more of glyceryl stearate, glyceryl stearate citrate, PEG-100 stearate, hydrogenated lecithin, cetearyl olive oleate, sorbitan olive oleate, potassium cetyl phosphate, Tween 20, Tween 60, polyglycerol-10-stearate.
6. The anti-aging composition comprising Brassica oleracea sprout extract as claimed in claim 2, wherein said pH adjusting agent is comprised of one or more of triethanolamine, sodium bicarbonate, potassium bicarbonate, sodium hydroxide, potassium hydroxide.
7. The method for preparing the anti-aging composition comprising the extract of Brassica oleracea sprouts as claimed in any one of claims 1 to 6, comprising the steps of:
(1) elutriating rape seeds for 2 times by using clean water at the temperature of 20-30 ℃, soaking the rape seeds in warm water with the volume 2-3 times and the temperature of 45 ℃ for 24 hours, then cleaning the seeds by using the clean water, filtering off water, and wrapping the seeds by using gauze at the temperature of 25 ℃ for accelerating germination for 48 hours; uniformly placing the seeds in a seedling raising tray paved with wet paper, covering the seedling raising tray with wet gauze, and spraying water for 2-3 times every day; the tenth day, cleaning the rape bud sample, then drying the water by using absorbent paper, freezing and drying the rape bud sample, and crushing the rape bud sample to obtain a rape bud crushed substance;
(2) pulverizing Heteropana leaf with a pulverizer 25000R/min to obtain Heteropana leaf pulverized material;
(3) taking 60-70% of butanediol by mass, and separately extracting the crushed rape bud and the crushed Heteropana leaf, wherein the mass fraction ratio of the crushed material to the butanediol is 1: 20-30 parts of; controlling the extraction temperature at 50-60 deg.C, performing ultrasonic treatment for 40-60min during extraction, and filtering after extraction to obtain vegetable bud powder extract and Heteropana leaf extract;
(4) taking 60-70% of butanediol, 0.1-0.5% of Tween 20 and 100-200PPM of palmitoyl pentapeptide-4 in percentage by mass, and carrying out ultrasonic treatment for 40-60min, wherein the temperature is controlled at 30-40 ℃ to obtain a palmitoyl pentapeptide-4 solution;
(5) heating 95-99% of polyglycerol-10-stearate and 1-5% of ceramide 3 by mass to 70-85 ℃, and cooling to obtain a ceramide 3 raw material;
(6) and weighing the obtained extract and other components according to the weight part ratio, and mixing with the weighed preservative, humectant, emulsifier and pH regulator to obtain the anti-aging composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111374299.3A CN113876671A (en) | 2021-11-19 | 2021-11-19 | Anti-aging composition containing rape bud extract and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111374299.3A CN113876671A (en) | 2021-11-19 | 2021-11-19 | Anti-aging composition containing rape bud extract and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113876671A true CN113876671A (en) | 2022-01-04 |
Family
ID=79015805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111374299.3A Pending CN113876671A (en) | 2021-11-19 | 2021-11-19 | Anti-aging composition containing rape bud extract and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113876671A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115813838A (en) * | 2022-12-07 | 2023-03-21 | 广州兰蝶生物科技有限公司 | Cosmetic with anti-aging composition and preparation method and application thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20130057534A (en) * | 2011-11-24 | 2013-06-03 | (주)아모레퍼시픽 | Cosmetic composition for anti-oxidation containing acaiberry extract and sprout extract |
| US20150024073A1 (en) * | 2013-07-22 | 2015-01-22 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing extracts of malva neglecta |
| CN108379173A (en) * | 2018-05-12 | 2018-08-10 | 佛山云裳化妆品有限公司 | A kind of silanol is dispelled pouch composition and application |
| CN108567729A (en) * | 2018-07-20 | 2018-09-25 | 广州澳希亚实业有限公司 | With cosmetic composition and its application for increasing skin elasticity and crease-resistant function |
| CN111686029A (en) * | 2020-07-28 | 2020-09-22 | 广州市柏亚化妆品有限公司 | Anti-aging wrinkle-removing composition |
-
2021
- 2021-11-19 CN CN202111374299.3A patent/CN113876671A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20130057534A (en) * | 2011-11-24 | 2013-06-03 | (주)아모레퍼시픽 | Cosmetic composition for anti-oxidation containing acaiberry extract and sprout extract |
| US20150024073A1 (en) * | 2013-07-22 | 2015-01-22 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing extracts of malva neglecta |
| CN108379173A (en) * | 2018-05-12 | 2018-08-10 | 佛山云裳化妆品有限公司 | A kind of silanol is dispelled pouch composition and application |
| CN108567729A (en) * | 2018-07-20 | 2018-09-25 | 广州澳希亚实业有限公司 | With cosmetic composition and its application for increasing skin elasticity and crease-resistant function |
| CN111686029A (en) * | 2020-07-28 | 2020-09-22 | 广州市柏亚化妆品有限公司 | Anti-aging wrinkle-removing composition |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115813838A (en) * | 2022-12-07 | 2023-03-21 | 广州兰蝶生物科技有限公司 | Cosmetic with anti-aging composition and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021020887A (en) | Enhanced anti-aging cosmetic composition | |
| CN108143702A (en) | A kind of efficient whitening and moisturizing facial mask liquid, facial mask and preparation method thereof | |
| CN108553389A (en) | A kind of plant moisturizing after-sun frost and preparation method thereof | |
| CN111388346A (en) | Freeze-dried powder live mask with vegetable protein and polypeptide formula and preparation method thereof | |
| CN108836919B (en) | Moisturizing cosmetic composition and preparation method and application thereof | |
| CN113398016A (en) | Skin soothing and repairing composition and cosmetic composition | |
| CN109330954B (en) | Whitening skin brightening lotion, preparation method thereof and tyrosinase inhibitor | |
| KR20120056594A (en) | Cosmetic composition containing SARGASSUM FULVELLUM extract, CODIUM FRAGILE extract and UNDARIA PINNATIFIDA extract | |
| CN110721148A (en) | Multidirectional pulling and tightening polypeptide essence and preparation method thereof | |
| CN114224779A (en) | Eye repair composition and application thereof | |
| CN104473860B (en) | Ganodermalucidumcollagen mask and preparation process thereof | |
| CN111450005A (en) | Beautifying and skin-brightening composition, beautifying and skin-brightening skin care product and preparation method thereof | |
| CN111265441A (en) | Composition capable of enhancing skin night repair and regeneration capacity and application thereof | |
| CN105267123A (en) | Whitening and hydrating toner and method for manufacturing same | |
| CN109381390A (en) | A kind of sodium hyaluronate skin lightening Face-protecting mask and preparation method thereof | |
| CN113876671A (en) | Anti-aging composition containing rape bud extract and preparation method thereof | |
| CN113143820A (en) | Anti-aging composition and preparation method thereof | |
| CN108635326A (en) | Anti-aging and wrinkle-removing composition containing dendrobium stem cell extract and application thereof | |
| CN115778870B (en) | Anti-wrinkle anti-aging composition, and preparation method and application thereof | |
| CN108771652B (en) | Plant skin care composition and skin cream with same | |
| CN110279644A (en) | A kind of composition with repair of releiving and its application in cosmetics | |
| KR101154772B1 (en) | Cosmetic composition containing the zizyphus jujuba fruit extract and walnut extract for moisturizing effect on the skin | |
| CN114344211A (en) | Moisturizing and stabilizing composition and preparation method thereof | |
| CN109646359B (en) | Rose-agaric mud membrane paste with effects of cleaning, purifying, maintaining beauty and keeping young and preparation method thereof | |
| CN111544335A (en) | Essence containing soluble collagen and malachite extract and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220104 |
|
| RJ01 | Rejection of invention patent application after publication |